Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
Revenue
Alliance Pharma PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Alliance Pharma PLC
LSE:APH
|
Revenue
£170m
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£30.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$45.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
Indivior PLC
LSE:INDV
|
Revenue
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Revenue
£761.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is Alliance Pharma PLC's Revenue?
Revenue
170m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Revenue amounts to 170m GBP.
What is Alliance Pharma PLC's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Alliance Pharma PLC have been 9% over the past three years , 10% over the past five years , and 14% over the past ten years .